Intel Slides After Proposing a $15 Billion Stock Sale to Fund Its Buildout

Intel shares fell in Monday trading after the company proposed a $15 billion sale of new common stock, a move that would raise cash for its growing chip investments while adding to the shares already outstanding. The stock traded at $98.64 in early Monday afternoon, down about 3% from Friday’s close of $101.65. New shares were the reason.

The offering, and why dilution weighs on the price

Intel said the sale is an underwritten public offering of common stock. The company gave its underwriters a 30-day option to buy up to $2.25 billion of additional shares at the offering price. J.P. Morgan, Goldman Sachs, Morgan Stanley and Citigroup are running the sale as joint book-running managers. Intel plans to use the proceeds for general corporate purposes, which it said may include capital expenditures and working capital.

New shares dilute existing holders. When a company issues stock, each share held already represents a slightly smaller claim on future earnings, and the price often drops to reflect it. That is the reaction traders delivered on Monday.

A capital budget that keeps growing

The raise lines up with a spending plan Intel has been enlarging. In July the company lifted its 2026 capital-expenditure guidance to about $20 billion from $18 billion, and it has signaled that the figure could rise again in 2027. Intel has tied the increase to demand for AI computing, pointing to orders for its manufacturing and packaging capacity as the reason it needs the cash.

Equity is a costly way to fund that bill, because every new share splits the same future profit more ways. Intel’s answer is that demand justifies it.

The stock’s climb gave Intel room to sell

Intel is raising money from a position of strength. The stock has more than doubled since early April, when it changed hands just above $48, and it sits more than fourfold above its 52-week low of $17.67. Selling shares after a long run lets a company raise more money for each share it issues, which softens the dilution for existing holders.

The advance has cooled since summer. Intel reached about $141 in late June, close to its 52-week high of $142.35, then pulled back into the $80s by late July before recovering toward $100 last week. Monday’s decline landed in the middle of that choppier stretch, about 30% below the June peak but far above where the stock started the year.

The size and price are still open

The offering’s terms are not final. The number of shares and the price will be set when the sale is completed, and the underwriters’ $2.25 billion option runs for 30 days after that. Intel’s capital-spending guidance is the other thing to track, since the company has framed the raise as fuel for it.

And there is the close itself. Monday’s figure is an intraday snapshot, and where the stock finishes the session will show how the market weighs the new cash against a larger share count.

This is a general-market summary for information only — not investment advice, and not a recommendation regarding any security.